Bone Biologics (BBLG) Return on Equity (2016 - 2017)
Bone Biologics (BBLG) has disclosed Return on Equity for 2 consecutive years, with 0.9% as the latest value for Q3 2017.
Bone Biologics (BBLG) has disclosed Return on Equity for 2 consecutive years, with 0.9% as the latest value for Q3 2017.